Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Artificial Valve Market by Type (Transcatheter Valve , Tissue Valve, Mechanical Valve), By Application (<20 Years Old, 20-30 Years Old, 30-50 Years Old, >50 Years Old) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Artificial Valve Market by Type (Transcatheter Valve , Tissue Valve, Mechanical Valve), By Application (<20 Years Old, 20-30 Years Old, 30-50 Years Old, >50 Years Old) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 129795 3300 Medical Devices & Consumables 377 236 Pages 4.7 (31)
                                          

Market Overview:


The global artificial valve market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of heart diseases, technological advancements in artificial valves, and rising demand for minimally invasive surgeries. The transcatheter valve segment is expected to grow at a CAGR of 6.0% from 2018 to 2030, owing to the increasing demand for minimally invasive surgeries and technological advancements in transcatheter valves.


Global Artificial Valve Industry Outlook


Product Definition:


An artificial valve is a device which substitutes for a natural heart valve. They are commonly used to treat conditions such as valvular heart disease.


Transcatheter Valve :


Transcatheter valve is a medical device used to treat heart failure and certain types of strokes. It's an alternative to the conventional method of cardiac valve replacement, which involves surgical implantation. Transcatheter valves are made up of materials such as polymeric resins or titanium and can be installed in the heart through minimally invasive techniques like transcatheter pulmonary valve, transcatheter mitral Valve repair & reconstruction or transcatheter aortic Valve replacement (TAVR).


Tissue Valve:


The tissue valve is a type of artificial heart valve used to prevent blood from clotting. It's main function is to allow blood flow through the heart without any problems. The artificial valves are made up of different types of materials such as sutures, polymers, and metallic stents which are placed in the heart by surgeons during open surgery or by using catheters in endoscopic surgeries.


These devices have different sizes.


Application Insights:


The application segment includes a younger than 20 years, ¢â‚¬Å“20 to 30 years old,¢â‚¬ 30-50 years old and above 50. The older population is more susceptible to diseases because of reduced immunity. Therefore, the demand for valves that are suitable for older people has increased. This application segment is expected to witness lucrative growth over the forecast period owing to rising geriatric population across the globe.


Regional Analysis:


North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D investments by various companies and an increase in healthcare expenditure as well as government funding for such initiatives. In addition, favorable reimbursement policies are also expected to drive growth over the next eight years.


Asia Pacific is anticipated to witness a lucrative growth rate during the forecast period owing to rising disposable income levels, improving healthcare infrastructure, and increasing awareness about advanced products & services among patients & their families and doctors in this region. Moreover, growing medical tourism industry due to low prices offered by countries like India for treatment of heart diseases is further driving demand from other regions of the world (excluding North America). For instance, according with a study published in International Journal of Medical Sciences Case Reports 2015; 2(1): e95-96.


Growth Factors:


  • Increasing prevalence of heart diseases and other cardiac disorders that require valve replacement surgeries
  • Growing demand for minimally invasive surgical procedures for replacing defective valves
  • Rising awareness about the benefits of using artificial valves over traditional mechanical valves
  • Technological advancements in the field of artificial valve manufacturing and design
  • increasing number of aging population who are at high risk for developing heart diseases

Scope Of The Report

Report Attributes

Report Details

Report Title

Artificial Valve Market Research Report

By Type

Transcatheter Valve , Tissue Valve, Mechanical Valve

By Application

<20 Years Old, 20-30 Years Old, 30-50 Years Old, >50 Years Old

By Companies

Colibri Heart Valve, Cytograft Tissue Engineering, Direct Flow Medical, Edwards Lifesciences, Heart Leaflet Technologies, Perouse Medical, ...

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

236

Number of Tables & Figures

166

Customization Available

Yes, the report can be customized as per your need.


Global Artificial Valve Market Report Segments:

The global Artificial Valve market is segmented on the basis of:

Types

Transcatheter Valve , Tissue Valve, Mechanical Valve

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

<20 Years Old, 20-30 Years Old, 30-50 Years Old, >50 Years Old

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Colibri Heart Valve
  2. Cytograft Tissue Engineering
  3. Direct Flow Medical
  4. Edwards Lifesciences
  5. Heart Leaflet Technologies
  6. Perouse Medical
  7. ...

Global Artificial Valve Market Overview


Highlights of The Artificial Valve Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Transcatheter Valve 
    2. Tissue Valve
    3. Mechanical Valve
  1. By Application:

    1. <20 Years Old
    2. 20-30 Years Old
    3. 30-50 Years Old
    4. >50 Years Old
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Artificial Valve Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Artificial Valve Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Artificial valves are medical devices that help patients with heart conditions breathe. They work by opening and closing to control the flow of air into and out of the lungs.

Some of the key players operating in the artificial valve market are Colibri Heart Valve, Cytograft Tissue Engineering, Direct Flow Medical, Edwards Lifesciences, Heart Leaflet Technologies, Perouse Medical.

The artificial valve market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Artificial Valve Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Artificial Valve Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Artificial Valve Market - Supply Chain
   4.5. Global Artificial Valve Market Forecast
      4.5.1. Artificial Valve Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Artificial Valve Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Artificial Valve Market Absolute $ Opportunity

5. Global Artificial Valve Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Artificial Valve Market Size and Volume Forecast by Type
      5.3.1. Transcatheter Valve 
      5.3.2. Tissue Valve
      5.3.3. Mechanical Valve
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Artificial Valve Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Artificial Valve Market Size and Volume Forecast by Application
      6.3.1. <20 Years Old
      6.3.2. 20-30 Years Old
      6.3.3. 30-50 Years Old
      6.3.4. >50 Years Old
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Artificial Valve Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Artificial Valve Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Artificial Valve Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Artificial Valve Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Artificial Valve Demand Share Forecast, 2019-2029

9. North America Artificial Valve Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Artificial Valve Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Artificial Valve Market Size and Volume Forecast by Application
      9.4.1. <20 Years Old
      9.4.2. 20-30 Years Old
      9.4.3. 30-50 Years Old
      9.4.4. >50 Years Old
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Artificial Valve Market Size and Volume Forecast by Type
      9.7.1. Transcatheter Valve 
      9.7.2. Tissue Valve
      9.7.3. Mechanical Valve
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Artificial Valve Demand Share Forecast, 2019-2029

10. Latin America Artificial Valve Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Artificial Valve Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Artificial Valve Market Size and Volume Forecast by Application
      10.4.1. <20 Years Old
      10.4.2. 20-30 Years Old
      10.4.3. 30-50 Years Old
      10.4.4. >50 Years Old
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Artificial Valve Market Size and Volume Forecast by Type
      10.7.1. Transcatheter Valve 
      10.7.2. Tissue Valve
      10.7.3. Mechanical Valve
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Artificial Valve Demand Share Forecast, 2019-2029

11. Europe Artificial Valve Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Artificial Valve Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Artificial Valve Market Size and Volume Forecast by Application
      11.4.1. <20 Years Old
      11.4.2. 20-30 Years Old
      11.4.3. 30-50 Years Old
      11.4.4. >50 Years Old
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Artificial Valve Market Size and Volume Forecast by Type
      11.7.1. Transcatheter Valve 
      11.7.2. Tissue Valve
      11.7.3. Mechanical Valve
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Artificial Valve Demand Share, 2019-2029

12. Asia Pacific Artificial Valve Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Artificial Valve Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Artificial Valve Market Size and Volume Forecast by Application
      12.4.1. <20 Years Old
      12.4.2. 20-30 Years Old
      12.4.3. 30-50 Years Old
      12.4.4. >50 Years Old
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Artificial Valve Market Size and Volume Forecast by Type
      12.7.1. Transcatheter Valve 
      12.7.2. Tissue Valve
      12.7.3. Mechanical Valve
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Artificial Valve Demand Share, 2019-2029

13. Middle East & Africa Artificial Valve Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Artificial Valve Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Artificial Valve Market Size and Volume Forecast by Application
      13.4.1. <20 Years Old
      13.4.2. 20-30 Years Old
      13.4.3. 30-50 Years Old
      13.4.4. >50 Years Old
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Artificial Valve Market Size and Volume Forecast by Type
      13.7.1. Transcatheter Valve 
      13.7.2. Tissue Valve
      13.7.3. Mechanical Valve
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Artificial Valve Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Artificial Valve Market: Market Share Analysis
   14.2. Artificial Valve Distributors and Customers
   14.3. Artificial Valve Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Colibri Heart Valve
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Cytograft Tissue Engineering
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Direct Flow Medical
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Edwards Lifesciences
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Heart Leaflet Technologies
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Perouse Medical
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. ...
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us